Susquehanna International Group
CTSO icon

Susquehanna International Group’s Cytosorbents Corp CTSO Stock Holding History

Susquehanna International Group’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,700
Closed -$15K – 12600
2022
Q3 		$15K Sell
10,700
-5,000
-32% -$9.77K ﹤0.01% 12695
2022
Q2 		$34K Buy
+15,700
New +$36K ﹤0.01% 12161
2022
Q1 		– Sell
-17,600
Closed -$74K – 13116
2021
Q4 		$74K Sell
17,600
-36,400
-67% -$204K ﹤0.01% 12330
2021
Q3 		$438K Sell
54,000
-56,900
-51% -$462K ﹤0.01% 9724
2021
Q2 		$837K Sell
110,900
-42,900
-28% -$361K ﹤0.01% 8251
2021
Q1 		$1.33M Buy
153,800
+104,400
+211% +$995K ﹤0.01% 6961
2020
Q4 		$394K Buy
49,400
+4,600
+10% +$38.5K ﹤0.01% 8758
2020
Q3 		$357K Sell
44,800
-800
-2% -$7.22K ﹤0.01% 8358
2020
Q2 		$451K Sell
45,600
-23,900
-34% -$219K ﹤0.01% 7572
2020
Q1 		$537K Buy
69,500
+55,300
+389% +$279K ﹤0.01% 6781
2019
Q4 		$55K Buy
+14,200
New +$61.9K ﹤0.01% 9321
2019
Q2 		– Sell
-15,200
Closed -$115K – 10286
2019
Q1 		$115K Buy
+15,200
New +$118K ﹤0.01% 8187
2018
Q3 		– Sell
-12,200
Closed -$139K – 9342
2018
Q2 		$139K Sell
12,200
-1,700
-12% -$16.1K ﹤0.01% 8891
2018
Q1 		$98K Sell
13,900
-14,600
-51% -$110K ﹤0.01% 8712
2017
Q4 		$185K Sell
28,500
-27,200
-49% -$173K ﹤0.01% 8337
2017
Q3 		$345K Sell
55,700
-14,400
-21% -$73.4K ﹤0.01% 7155
2017
Q2 		$301K Buy
70,100
+31,200
+80% +$137K ﹤0.01% 7590
2017
Q1 		$175K Buy
38,900
+28,800
+285% +$161K ﹤0.01% 8108
2016
Q4 		$55K Sell
10,100
-4,000
-28% -$21.9K ﹤0.01% 9263
2016
Q3 		$90K Sell
14,100
-10,200
-42% -$53K ﹤0.01% 7975
2016
Q2 		$111K Buy
24,300
+5,100
+27% +$22.2K ﹤0.01% 7970
2016
Q1 		$75K Sell
19,200
-9,700
-34% -$42.1K ﹤0.01% 8540
2015
Q4 		$161K Sell
28,900
-23,800
-45% -$162K ﹤0.01% 8598
2015
Q3 		$333K Sell
52,700
-20,800
-28% -$139K ﹤0.01% 7861
2015
Q2 		$454K Buy
+73,500
New +$500K ﹤0.01% 7809

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Susquehanna International Group's CTSO Position: Q1 2026 in Review

Susquehanna International Group reduced its Cytosorbents Corp (CTSO) stake by 64% in Q1 2026, selling an estimated $36.5K and leaving 29,945 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #12883.

Susquehanna International Group first reported a position in CTSO in Q1 2015 and has held it in 36 quarters since. The position peaked at $1.11M in Q3 2017. 50 funds tracked by Wall St. Rank hold CTSO as of Q1 2026.

  • Susquehanna International Group held 29,945 shares of Cytosorbents Corp worth $17K as of Q1 2026.
  • Susquehanna International Group sold 53,418 Cytosorbents Corp shares in Q1 2026, an estimated $36.5K.
  • Cytosorbents Corp made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12883 holding.
  • Susquehanna International Group first reported a position in Cytosorbents Corp in Q1 2015 and has held it in 36 quarters since.
  • Susquehanna International Group's Cytosorbents Corp position peaked at $1.11M in Q3 2017.
  • 50 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.